Importance: High-prevalence foci of amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) exist in Japanese on the Kii Peninsula of Japan and in the Chamorros of Guam. Clinical and neuropathologic similarities suggest that the disease in these 2 populations may be related. Recent findings showed that some of the Kii Peninsula ALS cases had pathogenic C9orf72 repeat expansions, a genotype that causes ALS in Western populations.
A
FOCUS OF HIGH-PREVAlence amyotrophic lateral sclerosis (ALS) was identified during World War II among the indigenous Chamorros of Guam. 1 Soon afterward, the related disorder parkinsonism-dementia complex (PDC) was characterized in the same population. 2 Neuropathologic findings in ALS-PDC include tangles, which occur in the hippocampus and neocortex and sometimes in anterior horn cells. 3 Environmental 4 and genetic 5 risk factors for ALS-PDC have been reported. Results of genetic studies show that polymorphisms in MAPT (Online Mendelian Inheritance in Man [OMIM] 157140), which encodes for tau increase risk, 5 but no mutations in MAPT or other genes are known to cause Guam ALS-PDC. [6] [7] [8] Linkage analysis of families with ALS-PDC suggest chromosome 12 loci. 9 Both ALS and PDC are also prevalent among Japanese living on the Kii Peninsula of Japan. 10 The results of clinical and neuropathology studies 11 suggest that ALS and PDC cases from the Kii Peninsula are similar to those observed on Guam and indicate that these 2 sites may represent foci of the same disorder.
The findings of recent work showed that expansion of a hexanucleotide repeat sequence in an intron of C9orf72 (OMIM 614260) causes autosomal dominant ALS and frontotemporal dementia. 12, 13 Parkinsonism is also observed in some cases of C9orf72 expansion.
14 A study 15 of Kii Peninsula families with ALS 
METHODS

PARTICIPANTS
Recruitment and diagnostic assessment procedures were described previously. 5, 16 The ALS-PDC cases and healthy control subjects were sampled on Guam between 1956 and 2006. Archival samples and clinical data were from the National Institute of Neurological and Communicative Disorders Research intramural program (1956 to 1983). Diagnoses were confirmed by examining clinical records and autopsy reports available for many of the participants (Table) . Other samples were obtained 1995 to 2006, from a neurological screening program. 17 Controls were Chamorros who were cognitively and neurologically healthy. The diagnosis of PDC required gradual onset and progression of primary parkinsonism and dementia. The diagnosis of ALS was based on El Escorial criteria. 18 All individuals (or proxies) provided written consent to participate in the study. Race/ethnicity was by self-report.
MUTATION SCREENING
The C9orf72 hexanucleotide repeat was genotyped using repeatprimed polymerase chain reaction as described. 12 The size of the hexanucleotide repeat-containing region was determined by allele fragment length analysis as previously described. 13 Only alleles with normal repeat lengths (range, 2-27) can be amplified by this procedure (Figure 1 insets). Participants with repeat numbers in great excess of 30 were considered to have pathogenic repeat expansions. All 51 exons of LRRK2 were screened by Sanger sequencing as previously described. 19 
RESULTS
Our results show that neither LRRK2 nor C9orf72 is the major gene responsible for ALS-PDC on Guam. We screened Guam residents with ALS and PDC and older control subjects with normal cognition (Table) for the C9orf72 pathogenic expanded hexanucleotide repeat that causes ALS in persons of white race/ethnicity. Some individuals with ALS and PDC and control subjects were from Umatac, a village with a higher disease incidence than that of other Guamanian villages. 1 All participants were Chamorros except for a single individual of white race/ethnicity with ALS who was born in the United States, moved to Guam as a young adult, and developed ALS at age 53 years. He had no family history of ALS. We observed a single case of an expanded pathogenic hexanucleotide repeat among individuals of white race/ ethnicity. The genotype was comparable to that of a previously described individual with a repeat expansion (ND06769*B1) 12 set). Therefore, ALS in this case was caused by a highly penetrant mutation and not by exposure to an environmental factor on Guam. All Chamorro participants had normal repeat lengths, with copy numbers ranging from 2 to 17 ( Figure 1B) . For LRRK2 screening, we screened 47 unrelated individuals with ALS and 92 unrelated individuals with PDC for mutations in exons 31, 35, and 41. These exons harbor the known pathogenic mutations. In 2 individuals with ALS, we found a new missense variant in exon 31 (H1453R). We then sequenced exon 31 in 341 Chamorro control subjects and identified one individual who was heterozygous for the variant. Finally, we sequenced all 51 LRRK2 exons in 16 affected members of a large Guamanian ALS-PDC pedigree from the village of Umatac with evidence of linkage to the LRRK2 region and detected no missense variants.
COMMENT
The genetic origin of Guamanian ALS-PDC remains largely unknown. MAPT alleles contribute to disease susceptibility but do not cause ALS-PDC. 5, 6 Findings from our work show that ALS-PDC in Chamorros is not caused by C9orf72 expansions or by LRRK2 mutations. Therefore, the primary genetic change responsible for this disorder requires further investigation.
In contrast, C9orf72 expansions seem to cause a subset of ALS cases from the southern Kii Peninsula. Also, some ALS cases from this region carry a low-penetrance SOD1 (OMIM 147450) mutation. 20 Still, most ALS and PDC cases from this region of Japan have no known genetic mutation. Therefore, while ALS on the Kii Peninsula is genetically heterogeneous, the genetic origin of unexplained cases may be similar to that of the Chamorro ALS-PDC cases.
LRRK2 is located on chromosome 12 and is close to the ALS-PDC linkage signal obtained in an extended family from the village of Umatac. 9 However, the H1453R variant was not observed in the Umatac cases and does not account for the chromosome 12 linkage signal. The H1453R variant was observed in 2 cases with ALS herein (with onset at age 42 years and age 43 years) and in a 69-year-old healthy Chamorro control subject. Therefore, although the histidine at position 1453 is conserved among vertebrates and in Drosophila (Figure 2) , it is unlikely pathogenic or at least is not fully penetrant. 
Accepted for
Homo sapiens FYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKIT
Mus musculus FYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHL D V S D E K Q R K A C I S K I T
Gallus gallus FYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASTSPVILVGTHLDVSDEKQHKDCMSKIT
Tetraodon nigroviridis FSGSHPHFLTSRALYLVVYNLSRGASQVDALKPWLFNIKAAAPVSPVILVGTHT D V S N E L Q L Q A C LT K I
Drosophila melanogaster YYATHQYFLSKRSLYLVLWRISDGHKGLAELLQWLGNIQARAPNSPVIIVGTHFDAVGE
Caenorhabditis elegans YHSTHQYFLSKRSLNLVLWKITDGDEALAQLDTWLVNIHARAPNSTVILVGTNLD R1441C R1441G R1441H H1453R Figure 2 . Alignment of the LRRK2 amino acid sequence corresponding to the human sequence of 1401 to 1470. H1453 occurs near 3 known pathogenic mutations (R1441C, R1441G, and R1441H).
